WHO ICTRP trial
An extension trial to trial NN1250-3583 comparing safety and efficacy of NN1250…
EUCTR2009-015755-24-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-015755-24-FR |
|---|---|
| Public title | An extension trial to trial NN1250-3583 comparing safety and efficacy of NN1250 with insulin glargine, both with insulin aspart as meal-time insulin, in type 1 diabetes - BEGIN™: T1 |
| Scientific title | An extension trial to trial NN1250-3583 comparing safety and efficacy of NN1250 with insulin glargine, both with insulin aspart as meal-time insulin, in type 1 diabetes - BEGIN™: T1 |
| Primary sponsor | Novo Nordisk A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Germany;United Kingdom |
| Conditions | Type 1 diabetes MedDRA version: 12.1 Level: LLT Classification code 10067584 Term: Type 1 diabetes mellitus |
| Interventions | Product Name: NN1250 Product Code: NN1250 Pharmaceutical Form: Solution for injection Current Sponsor code: 0100-0000-0454 Concentration unit: U/ml unit(s)/millilitre Concentration type: equal Concentration number: 100- Trade Name: Lantus… |
| Registration date | Feb 23, 2010 |
| Target size | 396 |
| Secondary IDs | NN1250-3644 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: